I think your logic is flawed. The latest quarterly simply...

I think your logic is flawed. The latest quarterly simply confirms what I am saying.

a) No organic revenue growth of note. All acquisition based.

b) Average of 400 patients per pharmacy per year! Given the average pharmacy does 4000 scripts a month, or 48,000 a year, MedAdvisor is hardly making a meaningful dent in pharmacies revenues. See point c) below.

c) $140m in script orders over the entire base PA equates to $51k per year per pharmacy! that is nothing!

d) Revenue increased (due to acquisitions) to $7.2m (51%), and loss increases 30%. Can't get excited by that.

e) And despite the failure to prove the model in Australia, they are now trying it offshore.

What is it that I am missing here? I would be very happy to be corrected with my understanding of the facts. As I have said, I like the idea. I think the app is ok. But something is going terribly wrong with adoption rates.